Peroxisome Proliferator-activated Receptor Agonist [EPC]

900 reported adverse events

Drugs of this class: ELAFIBRANOR

These side effects are most commonly reported by patients taking drugs of the Peroxisome Proliferator-activated Receptor Agonist [EPC] class:

# Side effect Count
0 FATIGUE 100
1 NAUSEA 86
2 PRURITUS 83
3 DIARRHOEA 74
4 PRODUCT DOSE OMISSION ISSUE 72
5 MYALGIA 68
6 CONSTIPATION 65
7 WEIGHT INCREASED 61
8 ARTHRALGIA 57
9 HEADACHE 44
See all common reactions for Peroxisome Proliferator-activated Receptor Agonist [EPC]

Drugs of the Peroxisome Proliferator-activated Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AUTOLOGOUS BLOOD PATCHING 1 0.2000
1 ANALGESIC DRUG LEVEL BELOW THERAPEUTIC 1 0.0714
2 HEPATIC EMBOLISATION 1 0.0127
3 PRODUCT INEFFECTIVE 7 0.0089
4 ENZYME LEVEL ABNORMAL 1 0.0071
5 CREATINE KINASE INCREASED 5 0.0065
6 LUMBAR PUNCTURE 2 0.0053
7 BLOOD ETHANOL INCREASED 1 0.0045
8 ALANINE AMINOTRANSFERASE 1 0.0045
9 CREATININE RENAL CLEARANCE ABNORMAL 2 0.0043
See all enriched reactions for Peroxisome Proliferator-activated Receptor Agonist [EPC]